Cantitate/Preț
Produs
Total produse
Vezi coșul
Ciprofloxacin i.v.: Defining Its Role in Serious Infections de Christopher Garrard

Ciprofloxacin i.v.: Defining Its Role in Serious Infections

Editat de Christopher Garrard
en Limba Engleză Paperback – 8 dec 2011
On the occasion of a symposium in Salzburg, an international team of clinicians and pharmacologists presented recent results in profile efficacy, safety and therapeutic use of the antibiotic substance Ciprofloxacin. Of special interest for clinicians will be the clinical outcome in patients with nosocomial pneumonia and other infections of the lower respiratory tract.
Citește tot Restrânge

Preț: 88022 lei

Preț vechi: 92654 lei
-5% Nou

Puncte Express: 1320
Preț estimativ în valută:
16843€ • 17787$ • 14017£

Carte tipărită la comandă

Livrare economică 11-25 ianuarie 25

 Adaugă în coș

Wish list
Gift list
Am citit!
Adaugă în listă
Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9783642791000
ISBN-10: 364279100X
Pagini: 160
Ilustrații: XIV, 146 p.
Dimensiuni: 155 x 235 x 8 mm
Greutate: 0.25 kg
Ediția:Softcover reprint of the original 1st ed. 1994
Editura: Springer Berlin, Heidelberg
Colecția Springer
Locul publicării:Berlin, Heidelberg, Germany

Public țintă

Research

Descriere

On the occasion of a symposium in Salzburg, an international team of clinicians and pharmacologists presented recent results in profile efficacy, safety and therapeutic use of the antibiotic substance Ciprofloxacin. Of special interest for clinicians will be the clinical outcome in patients with nosocomial pneumonia and other infections of the lower respiratory tract.

Cuprins

Effect of Quinolones Against Slowly Growing Bacteria.- The Postantibiotic Effect of Ciprofloxacin.- The Effects of Different Types of Antimicrobial Agents on Plasma Endotoxin Activity in Gram-Negative Bacterial Infection.- Dose-Finding Investigations of Intravenous Ciprofloxacin in a Pharmacodynamic Model.- The Relationship Between Ciprofloxacin Blood Concentrations, MIC Values, Bacterial Eradication, and Clinical Outcome in Patients with Nosocomial Pneumonia.- Efficacy and Safety of Ciprofloxacin in Various Intravenous Dosages.- Intravenous Ciprofloxacin Versus Imipenem/Cilastatin in the Treatment of Severe Pneumonia.- Conversion of Intravenous to Oral Ciprofloxacin: Observing the “Like-to-Like” Phenomenon.- Therapeutic Use of Quinolones in Oncology.- Ciprofloxacin in Neutropenic Host Infection.- Intravenous Ciprofloxacin for the Treatment of Lower Respiratory Tract Infections: Preliminary Results.- Integrated Safety Profile of Intravenous Ciprofloxacin.